Elixir Perspective on the Rx Pipeline - July 2020

Perspective on the Rx Pipeline: News on the approval of a vaccine for the bird flu and more

EnvisionRx continuously monitors the drug pipeline. Our team evaluates changing treatment options in order to educate and inform our clients on the most impactful medications in development, new drugs recently approved, generics being launched and current medications receiving new indications.

Clinical Pipeline

Within the extensive pipeline of drugs preparing for market launch, these are the three most notable drugs plan sponsors should be aware of:

Drug Approvals

Six drugs recently approved by the FDA include:

New Indications

Drugs that have gained FDA approval for the treatment of additional diseases and/or conditions and have potential to be impactful include:

Generic Approvals

There are several new generic product offerings to the marketplace, including drugs for the treatment of ADHD, cancer and HIV. A review of generic launches, including biosimilars, is provided in the full report.

Download the full report for more information, including important safety updates and drug shortages and discontinuations.